About Paul Kinnon

Paul has over 30 years of experience in the global life sciences industry, with the past 20 years of his executive career focused on Clinical Diagnostics and innovative products to improve patients’ lives. He has held leadership positions at PredictImmune, Transgenomic, ZyGEM Corp., Life Technologies (now ThermoFisher), Guava Technologies and Cellomics, raising more than £55m ($70m) in funding (from Series B up to Public investments), creating global partnerships and increasing shareholder return. Paul has spent over half of his career living and working in the USA running global businesses, which gives him a novel and unique outlook on the global industry; additionally he sits on a number of Boards as non-executive director (NED) for Life Science companies, where he mentors and provides guidance to other CEOs. Paul has a proven strategic and commercialisation track record of identifying and bringing novel technologies and products to global market rapidly and using the most effective & strategic channels, in addition to over ten years’ international Board experience in both private and public companies, with significant expertise in Corporate governance, Corporate restructuring, M&A and divestiture activities.